Azurity recalls mislabeled medicine that can cause death in those with ADHD, Narcolepsy

(Montana) Azurity Pharmaceuticals is recalling their Zenzedi medications in specific doses because some bottles were mislabeled and are actually a completely different medication.

The FDA says if those taking Zenzedi have a mislabeled bottle, they will not be treated for their symptoms properly and may experience side effects including functional impairment. The side effects are worse for individuals with ADHD or Narcolepsy says the FDA, as taking pills from the mislabeled bottles can result in injury or death for those individuals.

To date, Azurity has not received any reports of serious adverse events related to this recall. For more information, click here.